Raimo K. Tuominen - Concepedia

Author

Raimo K. Tuominen

Also Known As

P. Saarinen, R K Tuominen, R TUOMINEN, R Tuominen, R. K. TUOMINEN, R. K. Tuominen, R. Tuominen, R.K. Tuominen, RAIMO K. TUOMINEN, RAIMO TUOMINEN

188

Publications

4.1K

Citations

H-Index

135

Concepts

All Affiliations

University of Helsinki Minerva Foundation Åbo Akademi University National Institute of Environmental Health Sciences University of Eastern Finland

About

Raimo K. Tuominen is an author at University of Helsinki specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	50	2.5K
2	Social Sciences	16	19	1.5K
3	Natural Sciences	6	6	156
4	Health Sciences	2	2	358
5	Public Health	1	1	34

Raimo K. Tuominen

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo Päivi Lindholm, Merja H. Voutilainen, Juha Laurén, Nature Neurodegenerative DiseasesMolecular NeuroscienceNeuroprotectionNeuroscienceCell Biology	2007	437
Retarded Growth and Deficits in the Enteric and Parasympathetic Nervous System in Mice Lacking GFRα2, a Functional Neurturin Receptor Jari Rossi, Keijo Luukko, Dmitry Poteryaev, Neuron Mice Lacking Gfrα2Developmental BiologyBrain DevelopmentPhysiologyFunctional Neurturin Receptor	1999	285
Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease Merja H. Voutilainen, Susanne Bäck, Eeva Pörsti, Journal of Neuroscience Rat ModelSocial SciencesNeuroinflammationNeurobiology Of DiseaseNeurology	2009	267
Carcinogenicity of the Drinking Water Mutagen 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the Rat Hannu Komulainen, Sirkka-Liisa Vaittinen, Terttu Vartiainen, JNCI Journal of the National Cancer Institute	1997	158
Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease Merja H. Voutilainen, Susanne Bäck, Johan Peränen, Experimental Neurology NeurophysiologyMedicinePharmacologyNeuropharmacologyNeuroprotection	2010	136
CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice Mikko Airavaara, Brandon K. Harvey, Merja H. Voutilainen, Cell Transplantation NeurotransmitterMptp TreatmentNigrostriatal Dopamine SystemSocial SciencesPromotes Recovery	2011	132
MANF Promotes Differentiation and Migration of Neural Progenitor Cells with Potential Neural Regenerative Effects in Stroke Kuan-Yin Tseng, Jenni E. Anttila, Konstantin Khodosevich, Molecular Therapy	2017	100
Different <i>in vivo</i> properties of three new inhibitors of catechol <i>O</i>‐methyltransferase in the rat Pekka T. Männistö, Päivi Tuomainen, Raimo K. Tuominen British Journal of Pharmacology	1992	98
Amantadine protects dopamine neurons by a dual action: Reducing activation of microglia and inducing expression of GNDF in astroglia Bernardino Ossola, Nadia Schendzielorz, Shih‐Heng Chen, Neuropharmacology NeurophysiologyMedicineNeuropharmacologyBrain-immune InteractionNeuroprotection	2011	95
Gene therapy with <scp>AAV</scp>2‐<scp>CDNF</scp> provides functional benefits in a rat model of <scp>P</scp>arkinson's disease Susanne Bäck, Johan Peränen, Emilia Galli, Brain and Behavior In Vivo Gene TherapyAav2 VectorsImmunologyTherapeuticsRat Model	2013	92

Page 1